Molecular Diagnostics Market Size, Share, and Growth Forecast for 2025 - 2032

Molecular Diagnostics Market By Product Type (Instruments, Reagents, Consumables), Disease Area (Infectious Disease, Diabetes, Cardiology, Oncology, Others), End-use (Hospitals & Clinics, Diagnostic Laboratories, Academic and Research Institutes, Biopharmaceutical Companies), and Regional Analysis for 2025 – 2032

Market Growth and Regional Outlook Report by Persistence Market Research

PMRREP2784
12 Aug 2025 Healthcare
225 Pages

Table of Content

1. Executive Summary

1.1. Global Molecular Diagnostics Market Snapshot 2025 and 2032

1.2. Market Opportunity Assessment, 2025-2032, US$ Bn

1.3. Key Market Trends

1.4. Industry Developments and Key Market Events

1.5. Demand Side and Supply Side Analysis

1.6. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definitions

2.2. Value Chain Analysis

2.3. Macro-Economic Factors

2.3.1. Global GDP Outlook

2.3.2. Global GDP Outlook

2.3.3. Global economic Growth Forecast

2.3.4. Global Urbanization Growth

2.3.5. Other Macro-economic Factors

2.4. Forecast Factors – Relevance and Impact

2.5. COVID-19 Impact Assessment

2.6. PESTLE Analysis

2.7. Porter's Five Forces Analysis

2.8. Geopolitical Tensions: Market Impact

2.9. Regulatory and Technology Landscape

3. Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities

3.4. Trends

4. Price Trend Analysis, 2019 – 2032

4.1. Region-wise Price Analysis

4.2. Price by Segments

4.3. Price Impact Factors

5. Global Molecular Diagnostics Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)

5.1. Key Highlights

5.2. Global Molecular Diagnostics Market Outlook: Product Type

5.2.1. Introduction/Key Findings

5.2.2. Historical Market Size (US$ Bn) Analysis by Product Type, 2019-2024

5.2.3. Current Market Size (US$ Bn) Forecast, by Product Type, 2025-2032

5.2.3.1. Instruments

5.2.3.1.1. Polymerase Chain Reaction (PCR) Systems

5.2.3.1.2. Hybridization (In-Situ Hybridization & Fish) Systems

5.2.3.1.3. DNA Sequencing and Next-Generation Sequencing Platforms

5.2.3.1.4. Microarrays

5.2.3.2. Reagent

5.2.3.2.1. Antibodies

5.2.3.2.2. DNA Template

5.2.3.2.3. DNA Polymerase

5.2.3.2.4. Oligonucleotide Primers

5.2.3.2.5. Deoxyribonucleotide Triphosphate (dNTPs)

5.2.3.2.6. Buffer

5.2.3.3. Assay Kits

5.2.3.4. Consumables

5.2.4. Market Attractiveness Analysis: Product Type

5.3. Global Molecular Diagnostics Market Outlook: Disease Area

5.3.1. Introduction/Key Findings

5.3.2. Historical Market Size (US$ Bn) Analysis by Disease Area, 2019-2024

5.3.3. Current Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032

5.3.3.1. Infectious Disease

5.3.3.2. Diabetes

5.3.3.3. Cardiology

5.3.3.4. Oncology

5.3.3.5. Nephrology

5.3.3.6. Autoimmune Disease

5.3.3.7. Dermatology

5.3.3.8. Wound Care

5.3.3.9. Others

5.3.4. Market Attractiveness Analysis: Disease Area

5.4. Global Molecular Diagnostics Market Outlook: End-use

5.4.1. Introduction/Key Findings

5.4.2. Historical Market Size (US$ Bn) Analysis by End-use, 2019-2024

5.4.3. Current Market Size (US$ Bn) Forecast, by End-use, 2025-2032

5.4.3.1. Hospitals & Clinics

5.4.3.2. Diagnostics Laboratories

5.4.3.3. Academic and Research Institutes

5.4.3.4. Biopharmaceutical Companies

5.4.4. Market Attractiveness Analysis: End-use

6. Global Molecular Diagnostics Market Outlook: Region

6.1. Key Highlights

6.2. Historical Market Size (US$ Bn) Analysis by Region, 2019-2024

6.3. Current Market Size (US$ Bn) Forecast, by Region, 2025-2032

6.3.1. North America

6.3.2. Europe

6.3.3. East Asia

6.3.4. South Asia & Oceania

6.3.5. Latin America

6.3.6. Middle East & Africa

6.4. Market Attractiveness Analysis: Region

7. North America Molecular Diagnostics Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)

7.1. Key Highlights

7.2. Pricing Analysis

7.3. North America Market Size (US$ Bn) Forecast, by Country, 2025-2032

7.3.1. U.S.

7.3.2. Canada

7.4. North America Market Size (US$ Bn) Forecast, by Product Type, 2025-2032

7.4.1. Instruments

7.4.1.1. Polymerase Chain Reaction (PCR) Systems

7.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems

7.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms

7.4.1.4. Microarrays

7.4.2. Reagent

7.4.2.1. Antibodies

7.4.2.2. DNA Template

7.4.2.3. DNA Polymerase

7.4.2.4. Oligonucleotide Primers

7.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)

7.4.2.6. Buffer

7.4.3. Assay Kits

7.4.4. Consumables

7.5. North America Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032

7.5.1. Infectious Disease

7.5.2. Diabetes

7.5.3. Cardiology

7.5.4. Oncology

7.5.5. Nephrology

7.5.6. Autoimmune Disease

7.5.7. Dermatology

7.5.8. Wound Care

7.5.9. Others

7.6. North America Market Size (US$ Bn) Forecast, by End-use, 2025-2032

7.6.1. Hospitals & Clinics

7.6.2. Diagnostics Laboratories

7.6.3. Academic and Research Institutes

7.6.4. Biopharmaceutical Companies

8. Europe Molecular Diagnostics Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)

8.1. Key Highlights

8.2. Pricing Analysis

8.3. Europe Market Size (US$ Bn) Forecast, by Country, 2025-2032

8.3.1. Germany

8.3.2. Italy

8.3.3. France

8.3.4. U.K.

8.3.5. Spain

8.3.6. Russia

8.3.7. Rest of Europe

8.4. Europe Market Size (US$ Bn) Forecast, by Product Type, 2025-2032

8.4.1. Instruments

8.4.1.1. Polymerase Chain Reaction (PCR) Systems

8.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems

8.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms

8.4.1.4. Microarrays

8.4.2. Reagent

8.4.2.1. Antibodies

8.4.2.2. DNA Template

8.4.2.3. DNA Polymerase

8.4.2.4. Oligonucleotide Primers

8.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)

8.4.2.6. Buffer

8.4.3. Assay Kits

8.4.4. Consumables

8.5. Europe Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032

8.5.1. Infectious Disease

8.5.2. Diabetes

8.5.3. Cardiology

8.5.4. Oncology

8.5.5. Nephrology

8.5.6. Autoimmune Disease

8.5.7. Dermatology

8.5.8. Wound Care

8.5.9. Others

8.6. Europe Market Size (US$ Bn) Forecast, by End-use, 2025-2032

8.6.1. Hospitals & Clinics

8.6.2. Diagnostics Laboratories

8.6.3. Academic and Research Institutes

8.6.4. Biopharmaceutical Companies

9. East Asia Molecular Diagnostics Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)

9.1. Key Highlights

9.2. Pricing Analysis

9.3. East Asia Market Size (US$ Bn) Forecast, by Country, 2025-2032

9.3.1. China

9.3.2. Japan

9.3.3. South Korea

9.4. East Asia Market Size (US$ Bn) Forecast, by Product Type, 2025-2032

9.4.1. Instruments

9.4.1.1. Polymerase Chain Reaction (PCR) Systems

9.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems

9.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms

9.4.1.4. Microarrays

9.4.2. Reagent

9.4.2.1. Antibodies

9.4.2.2. DNA Template

9.4.2.3. DNA Polymerase

9.4.2.4. Oligonucleotide Primers

9.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)

9.4.2.6. Buffer

9.4.3. Assay Kits

9.4.4. Consumables

9.5. East Asia Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032

9.5.1. Infectious Disease

9.5.2. Diabetes

9.5.3. Cardiology

9.5.4. Oncology

9.5.5. Nephrology

9.5.6. Autoimmune Disease

9.5.7. Dermatology

9.5.8. Wound Care

9.5.9. Others

9.6. East Asia Market Size (US$ Bn) Forecast, by End-use, 2025-2032

9.6.1. Hospitals & Clinics

9.6.2. Diagnostics Laboratories

9.6.3. Academic and Research Institutes

9.6.4. Biopharmaceutical Companies

10. South Asia & Oceania Molecular Diagnostics Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)

10.1. Key Highlights

10.2. Pricing Analysis

10.3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2025-2032

10.3.1. India

10.3.2. Southeast Asia

10.3.3. ANZ

10.3.4. Rest of SAO

10.4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Product Type, 2025-2032

10.4.1. Instruments

10.4.1.1. Polymerase Chain Reaction (PCR) Systems

10.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems

10.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms

10.4.1.4. Microarrays

10.4.2. Reagent

10.4.2.1. Antibodies

10.4.2.2. DNA Template

10.4.2.3. DNA Polymerase

10.4.2.4. Oligonucleotide Primers

10.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)

10.4.2.6. Buffer

10.4.3. Assay Kits

10.4.4. Consumables

10.5. South Asia & Oceania Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032

10.5.1. Infectious Disease

10.5.2. Diabetes

10.5.3. Cardiology

10.5.4. Oncology

10.5.5. Nephrology

10.5.6. Autoimmune Disease

10.5.7. Dermatology

10.5.8. Wound Care

10.5.9. Others

10.6. South Asia & Oceania Market Size (US$ Bn) Forecast, by End-use, 2025-2032

10.6.1. Hospitals & Clinics

10.6.2. Diagnostics Laboratories

10.6.3. Academic and Research Institutes

10.6.4. Biopharmaceutical Companies

11. Latin America Molecular Diagnostics Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)

11.1. Key Highlights

11.2. Pricing Analysis

11.3. Latin America Market Size (US$ Bn) Forecast, by Country, 2025-2032

11.3.1. Brazil

11.3.2. Mexico

11.3.3. Rest of LATAM

11.4. Latin America Market Size (US$ Bn) Forecast, by Product Type, 2025-2032

11.4.1. Instruments

11.4.1.1. Polymerase Chain Reaction (PCR) Systems

11.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems

11.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms

11.4.1.4. Microarrays

11.4.2. Reagent

11.4.2.1. Antibodies

11.4.2.2. DNA Template

11.4.2.3. DNA Polymerase

11.4.2.4. Oligonucleotide Primers

11.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)

11.4.2.6. Buffer

11.4.3. Assay Kits

11.4.4. Consumables

11.5. Latin America Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032

11.5.1. Infectious Disease

11.5.2. Diabetes

11.5.3. Cardiology

11.5.4. Oncology

11.5.5. Nephrology

11.5.6. Autoimmune Disease

11.5.7. Dermatology

11.5.8. Wound Care

11.5.9. Others

11.6. Latin America Market Size (US$ Bn) Forecast, by End-use, 2025-2032

11.6.1. Hospitals & Clinics

11.6.2. Diagnostics Laboratories

11.6.3. Academic and Research Institutes

11.6.4. Biopharmaceutical Companies

12. Middle East & Africa Molecular Diagnostics Market Outlook: Historical (2019 – 2024) and Forecast (2025 – 2032)

12.1. Key Highlights

12.2. Pricing Analysis

12.3. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2025-2032

12.3.1. GCC Countries

12.3.2. South Africa

12.3.3. Northern Africa

12.3.4. Rest of MEA

12.4. Middle East & Africa Market Size (US$ Bn) Forecast, by Product Type, 2025-2032

12.4.1. Instruments

12.4.1.1. Polymerase Chain Reaction (PCR) Systems

12.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems

12.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms

12.4.1.4. Microarrays

12.4.2. Reagent

12.4.2.1. Antibodies

12.4.2.2. DNA Template

12.4.2.3. DNA Polymerase

12.4.2.4. Oligonucleotide Primers

12.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)

12.4.2.6. Buffer

12.4.3. Assay Kits

12.4.4. Consumables

12.5. Middle East & Africa Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032

12.5.1. Infectious Disease

12.5.2. Diabetes

12.5.3. Cardiology

12.5.4. Oncology

12.5.5. Nephrology

12.5.6. Autoimmune Disease

12.5.7. Dermatology

12.5.8. Wound Care

12.5.9. Others

12.6. Middle East & Africa Market Size (US$ Bn) Forecast, by End-use, 2025-2032

12.6.1. Hospitals & Clinics

12.6.2. Diagnostics Laboratories

12.6.3. Academic and Research Institutes

12.6.4. Biopharmaceutical Companies

13. Competition Landscape

13.1. Market Share Analysis, 2024

13.2. Market Structure

13.2.1. Competition Intensity Mapping

13.2.2. Competition Dashboard

13.3. Company Profiles

13.3.1. Becton, Dickinson and Company

13.3.1.1. Company Overview

13.3.1.2. Product Portfolio/Offerings

13.3.1.3. Key Financials

13.3.1.4. SWOT Analysis

13.3.1.5. Company Strategy and Key Developments

13.3.2. Bio-Rad Laboratories In

13.3.3. Merck KgaA

13.3.4. Thermo Fisher Scientific Inc

13.3.5. Agilent Technologies, Inc.

13.3.6. F. Hoffman - La Roche Ltd.

13.3.7. Illumina, Inc.

13.3.8. Qiagen N.V.

13.3.9. Hologic Inc.

13.3.10. Siemens Healthineers AG

13.3.11. Seegene, Inc.

13.3.12. DiaSorin S.p.A

13.3.13. Grifols, S.A.

13.3.14. bioMérieux

13.3.15. QuidelOrtho Corporation

14. Appendix

14.1. Research Methodology

14.2. Research Assumptions

14.3. Acronyms and Abbreviations

 

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate